We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PHARMACEUTICAL FORMULATIONS WARNED FOR cGMP VIOLATIONS
PHARMACEUTICAL FORMULATIONS WARNED FOR cGMP VIOLATIONS
June 7, 2004
The nation’s second-largest manufacturer of private-label OTC products was recently slapped with an FDA warning letter documenting more than a dozen deviations from cGMP regulations.